KEYNOTE-522 | Chemo + Pembro in neoadjuvant TNBC | subgroup updates by stage, nodal status, PDL1 status, chemo exposure #bcsm#SABCS19
Dr. Schmid’s background slide was a good summary. #bcsm#SABCS19
I think this slide provides some really interesting data around what happens when we discontinue chemo early in patients with early-stage breast cancer. Can’t wait to see the published data. #bcsm#SABCS19
• • •
Missing some Tweet in this thread? You can try to
force a refresh
Some persons, through absolutely no fault of their own, present with metastatic disease.
In some persons, through absolutely no fault of their own, breast cancer comes back in another part of their body. #bcsm#bcam /2
Persons with zero risk factors are diagnosed with the disease. It does not matter if you do not have a family history. It does not matter if you faithfully do your mammogram (mammos detect early, they don’t prevent). #bcsm#bcam /3
T2
KAITLIN randomized patients after adriacymycin/cyclophosphamide to either paclitaxel/trastuzumab/pertuzumab or TDM-1/pertuzumab. #bcsm
The two arms were nearly identical for primary endpoint IDFS, subsequently a “ negative “ trial. This trial raises all sorts of questions and controversies. Based on TRAIN-2, the administration of anthracycline to all patients likely could have been avoided #bcsm
Additionally, we have little data about the specific benefits of adding pertuzumab to TDM-1. #bcsm
America,
In WW1, America lost 116,516 people, with over half (63,114) of those deaths attributed to influenza/disease rather than combat. I know these figures because #KansasCity is home to the remarkable the National WW1 museum. You should visit when this is all over.
Thread/1
But as I watch the numbers unfold and read the predictions, I can’t help but wonder—where will the international COVID19 memorial be located? New York? They already currently have 1552 #COVID19 deaths.
On September 11 there were 2,997 victims /2
There were indications that use of any antioxidant supplement (vitamins A, C, and E; carotenoids; coenzyme Q10) both before and during treatment was associated with an increased hazard of recurrence (adjusted hazard ratio [adjHR], 1.41; 95% CI, 0.98 to 2.04; P = .06) /2
Relationships with individual antioxidants were weaker perhaps because of small numbers. For nonantioxidants, vitamin B12 use both before and during chemotherapy was significantly associated with poorer disease-free survival (adjHR, 1.83; 95% CI, 1.15 to 2.92; P < .01)... /3
Dr. Marks says radiation (XRT) technique allows for both better treatment planning for treating disease area and to minimize collateral damage (heart, lung) #SABCS19